Information Provided By:
Fly News Breaks for February 12, 2019
CASM
Feb 12, 2019 | 12:23 EDT
Craig-Hallum analyst Matthew Hewitt downgraded CAS Medical (CASM) to Hold from Buy citing the company's agreement to be acquired by Edwards Lifesciences (EW) in an all-cash transaction for $2.45 per share.
News For CASM From the Last 2 Days
There are no results for your query CASM